Purchase Order 75N95C25P00119

Award Date 9/30/25
Potential Completion Date 9/29/26
Potential Value $25K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services, awarded a firm-fixed-price purchase order to Inte:ligand Software-Entwicklungs- UND Consulting GMBH, an Austrian company, for the renewal of licenses to the LigandScout software suite. The contract award value is $23,990.00 and has an ultimate completion date of September 25, 2024. LigandScout provides molecular modeling and drug discovery informatics tools to...
The National Center for Advancing Translational Sciences, a civilian agency within the U.S. Department of Health and Human Services, awarded a $22,990.00 firm-fixed-price purchase order to Inte:ligand Software-Entwicklungs- UND Consulting GMBH, an Austrian company, for the renewal of licenses to the company's LigandScout software suite. LigandScout provides molecular modeling and drug discovery informatics tools to support the agency's translational sciences programs. This is one of several...
This is a firm-fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the Department of Health and Human Services National Institutes of Health, to Inte:ligand Software-Entwicklungs- UND Consulting GmbH, an Austrian company. The $25,990.00 contract is for the one-year renewal of licenses to the company's LigandScout software suite, which provides molecular modeling and drug discovery informatics tools to support NCATS' translational...
The National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services (HHS), awarded a $206,440.00 firm-fixed-price purchase order to Schrodinger LLC, a subsidiary of Schrodinger, Inc., for the renewal of licenses for the Small Molecule Drug Discovery Suite software. This non-competitive award was made without a set-aside designation to Schrodinger, a leading provider of computational drug design solutions for the...
This is a $82,823.54 firm fixed-price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency of the National Institutes of Health (NIH), to Cresset Biomolecular Discovery LIMITED, a for-profit organization based in the United Kingdom. The contract is for a software license for 5 users to aid NCATS' chemists with 3D structure-activity relationship (SAR) analysis, generation of novel and diverse molecular structures using...
The National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), awarded a $26,870 sole-source purchase order to Caerus US 1 Inc., operating as Citeline, to provide five one-year licenses for its Biomedtracker database and five one-year licenses for the Enhanced Company Deals Upgrade. These software tools will support NCATS' work on intellectual property issues, patent filing, and industry partnerships by providing access to a comprehensive...
This federal contract award was issued by the National Center for Advancing Translational Sciences (NCATS), which is part of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS). The contract, valued at $42,500.00, was awarded to Adeptia Inc. for the provision of Adeptia Connect ETL (Extract, Transform, Load) data mapping software licenses and support services. The original solicitation was a non-competitive combined synopsis/solicitation for commercial...
The National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services, awarded a $87,500.00 firm-fixed-price purchase order to Chemaxon LLC for a 5-year renewal and support of cheminformatics software licenses. The software, which includes products like JChem Oracle Cartridge, Marvin JS, and Instant JChem Enterprise, supports NCATS' initiatives in biotechnology and pharmaceutical research, such as the Preclinical Screening Platform...
This is a $180,000 firm fixed price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a division of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS), to Adeptia Inc. for the license renewal of their Adeptia Connect ETL data mapping software. The contract was awarded on August 10, 2021 and has an ultimate completion date of March 31, 2022. It was a sole-source acquisition of exclusively...
The U.S. National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) awarded a $96,550 firm fixed-price purchase order to Altoris, Inc., a for-profit software consulting company, for a 1-year subscription to the SARvision SM software license with two 1-year option periods. This sole-source award, made under simplified acquisition procedures, provides continued access to Altoris' proprietary SARvision SM software to support NCATS' translational sciences...

The National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health within the Department of Health and Human Services, awarded a $24,990 firm-fixed-price purchase order to Inte:ligand Software-Entwicklungs- UND Consulting GMBH, an Austrian software development and consulting firm. The contract is for the renewal of a license for Inte:ligand's LigandScout software, which provides computer-aided design solutions to support scientists worldwide in early drug discovery research. The LigandScout software includes capabilities for pharmacophore-based modeling, virtual screening, molecular design, and structure-activity relationship analysis. This contract does not utilize any set-aside designations, and the period of performance runs from September 30, 2025, through September 29, 2026. The place of performance is located in Potomac, Maryland.

Generated 9/30/25, 10:06 AM